Confirmed last summer, the spin-off had in fact been anticipated for several years. In any case, it fits in perfectly with the strategic logic pursued by Novartis since the appointment of Vasant Narasimhan.
It will be interesting to see what the Group’s historical shareholders do with their n…
© MarketScreener.com 2023
It will be interesting to see what the Group’s historical shareholders do with their n…
© MarketScreener.com 2023